BCBS Mississippi Medical Policy Updates – September 2022

Click here to view the Blue Cross Blue Shield BCBS Mississippi Medical Policy Updates »

September 2022 BCBS Mississippi Medical Policy Updates:

• Accelerated Breast Irradiation and Brachytherapy Boost After Breast-Conserving Surgery for Early-Stage Breast Cancer
• Adjunctive Techniques for Screening and Surveillance of Barrett Esophagus and Esophageal Dysplasia
• Anti-Rheumatic Biologicals – Effective 04/01/2018
• Artificial Pancreas Device Systems
• Automated Ambulatory Blood Pressure Monitoring for the Diagnosis of Hypertension in Patients with Elevated Office Blood Pressure
• Brachytherapy for Clinically Localized Prostate Cancer Using Permanently Implanted Seeds
• BRAF Gene Variant Testing To Select Melanoma or Glioma Patients for Targeted Therapy
• Cellular Immunotherapy for Prostate Cancer
• Chimeric Antigen Receptor Therapy for Leukemia and Lymphoma
• Chronic Plaque Psoriasis – Effective 04/01/2018
• Crohn’s Disease and Ulcerative Colitis – Effective 04/01/2018
• Cryoablation, Radiofrequency Ablation, and Laser Ablation for Treatment of Chronic Rhinitis
• Cryosurgical Ablation of Miscellaneous Solid Tumors Other Than Liver, Prostate, or Dermatologic Tumors
• Digital Health Therapies for Attention Deficit/Hyperactivity Disorder
• Electronic Brachytherapy for Nonmelanoma Skin Cancer
• Endobronchial Brachytherapy
• Gender Dysphoria Treatment in Adults
• Genetic Testing for Alzheimer Disease
• Genetic Testing for Diagnosis and Management of Mental Health Conditions
• Genetic Testing for Lactase Insufficiency
• Genetic Testing for Li-Fraumeni Syndrome
• Genotype-Guided Tamoxifen Treatment
• High-Dose Rate Temporary Prostate Brachytherapy
• Hydrogel Spacer Use During Radiotherapy for Prostate Cancer
• Hyperthermic Intraperitoneal Chemotherapy for Select Intra-Abdominal and Pelvic Malignancies
• Injectable Asthma Agents
• Intensity Modulated Radiation Therapy (IMRT) Abdomen and Pelvis
• Intensity-Modulated Radiatiotherapy (IMRT) of the Prostate
• Intensity-Modulated Radiotherapy of the Breast and Lung
• Intensity-Modulated Radiotherapy: Cancer of the Head and Neck or Thyroid
• Intensity-Modulated Radiotherapy: Central Nervous System Tumors
• Intracavitary Balloon Catheter Brain Brachytherapy for Malignant Gliomas or Metastasis to the Brain
• Intraoperative Radiotherapy
• Laser Interstitial Thermal Therapy for Neurological Conditions
• Lysosomal Storage Disorders
• Magnetic Resonance-Guided Focused Ultrasound
• Miscellaneous Genetic and Molecular Diagnostic Tests
• Molecular Testing for the Management of Pancreatic Cysts, Barrett Esophagus, and Solid Pancreaticobiliary Lesions
• Non-Invasive Positive Airway Pressure for Chronic Obstructive Pulmonary Disease
• Oncologic Applications of Photodynamic Therapy, Including Barrett’s Esophagus
• Percutaneous Electrical Nerve Stimulation (PENS) and Percutaneous Neuromodulation Therapy (PNT)
• Radioembolization for Primary and Metastatic Tumors of the Liver
• Radiofrequency Ablation of Primary or Metastatic Liver Tumors
• Risk-Reducing Mastectomy
• Saturation Biopsy for Diagnosis, Staging, and Management of Prostate Cancer
• Serologic Genetic and Molecular Screening for Colorectal Cancer
• Sleep Disorders – Effective 01/01/2018
• Sleep Disorders – Effective 01/01/2018
• Spinraza (Nusinersen)
• Synthetic Cartilage Implants for Joint Pain
• Telehealth: Real-Time Interactive Telemedicine Services
• Telehealth: Real-Time Interactive Telemedicine Services
• Telehealth: Remote Patient Monitoring Services
• Telehealth: Remote Patient Monitoring Services
• Telehealth: Store-and-Forward Telemedicine Services
• Transcatheter Arterial Chemoembolization to Treat Primary or Metastatic Liver Malignancies
• Transcutaneous Electrical Nerve Stimulator (TENS)
• Tumor Treating Fields Therapy
• Use of Common Genetic Variants (Single Nucleotide Variants) to Predict Risk of Nonfamilial Breast Cancer
• Welireg (belzutifan)

Click here to view the Blue Cross Blue Shield BCBS Mississippi Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.